Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 12


Results: 17
    1
    2
    3
    4
    5

    A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations (JMTO LC12‐01).

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 12, p. 1827, doi. 10.1111/1759-7714.14465
    By:
    • Asami, Kazuhiro;
    • Ando, Masahiko;
    • Nishimura, Takashi;
    • Yokoi, Takashi;
    • Tamura, Atsuhisa;
    • Minato, Koichi;
    • Mori, Masahide;
    • Ogushi, Fumitaka;
    • Yamamoto, Akiyoshi;
    • Yoshioka, Hiroshige;
    • Kawahara, Masaaki;
    • Atagi, Shinji
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Issue Information.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 12, p. 1749, doi. 10.1111/1759-7714.14026
    Publication type:
    Article